Publication: A novel EGFR Inhibitor, HNPMI regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer.
dc.contributor.author | Kandhavelu J. | |
dc.contributor.author | Subramanian K. | |
dc.contributor.author | Naidoo V. | |
dc.contributor.author | Sebastianelli G. | |
dc.contributor.author | Doan P. | |
dc.contributor.author | Mani S. K. | |
dc.contributor.author | Yapislar H. | |
dc.contributor.author | Haciosmanoglu E. | |
dc.contributor.author | Arslan L. | |
dc.contributor.author | Ozer S. | |
dc.contributor.author | et al. | |
dc.contributor.institutionauthor | HACIOSMANOĞLU, EBRU | |
dc.date.accessioned | 2023-08-28T21:50:10Z | |
dc.date.available | 2023-08-28T21:50:10Z | |
dc.date.issued | 2023-05-15 | |
dc.identifier.citation | Kandhavelu J., Subramanian K., Naidoo V., Sebastianelli G., Doan P., Mani S. K., Yapislar H., Haciosmanoglu E., Arslan L., Ozer S., et al., "A novel EGFR Inhibitor, HNPMI regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer.", British journal of pharmacology, 2023 | |
dc.identifier.doi | 10.1111/bph.16141 | |
dc.identifier.issn | 0007-1188 | |
dc.identifier.pubmed | 37183661 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12645/38533 | |
dc.relation.ispartof | British journal of pharmacology | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | A novel EGFR Inhibitor, HNPMI regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer. | |
dc.type | Article | |
dspace.entity.type | Publication | |
local.avesis.id | ef480f3f-0c8a-4725-865e-378b30e98bfa | |
relation.isAuthorOfPublication | fffb1a2f-62c4-40ee-8fc4-f0f3e62523b9 | |
relation.isAuthorOfPublication.latestForDiscovery | fffb1a2f-62c4-40ee-8fc4-f0f3e62523b9 |